Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell ...
A trusted, resilient global supply chain is a critical component of bringing products to life for your customers. In the face of increasing uncertainty and disruption in the world, our diverse supply ...